Felipe Arteaga-García has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Multisystemic Inflammatory Syndrome Temporally Associated with COVID-19 in a Regional Pediatric Hospital from México

    by Joel Barroso-Santos, Angelina Ingrid Robledo-Martínez, Sara Elva Espinosa-Padilla, Rubén Genaro Hurtado del Ángel, Felipe Arteaga-García, Mónica Langarica-Bulos, José Antonio Madrid-Gómez-Tagle, Beatriz Adriana Sánchez-Reyes, Sarai Eunice Hernández-Cadena, Jorge Iván Suárez-Soto, et al.

    Multisystemic inflammatory syndrome (MIS-C) is an inflammatory condition temporally associated with COVID-19 in children; nevertheless, the clinical and immunologic spectrum of MIS-C is heterogeneous, and its long-term effects are unknown. During the period of August 2020 to December 2021, a total of 52 MIS-C cases were confirmed in pediatric patients from the Hospital del Niño DIF Hidalgo, diagnosed using criteria from the World Health Organization. All patients had serologic IgG confirmation of SARS-CoV2, the mean age of the patients was 7 years, and 94% of the patients did not have a previous underlying disease. In addition to the presentation of lymphopenia, neutropenia, and thrombocytopenia, elevations in D-dimer and ferritin levels were observed in all patients. There was clinical improvement with intravenous gamma globulin and corticosteroid treatment.


  • Open Access

    Antiretroviral Therapy-Induced Dysregulation of Gene Expression and Lipid Metabolism in HIV+ Patients: Beneficial Role of Antioxidant Phytochemicals

    by Angélica Saraí Jiménez-Osorio, Sinaí Jaen-Vega, Eduardo Fernández-Martínez, María Araceli Ortíz-Rodríguez, María Fernanda Martínez-Salazar, Reyna Cristina Jiménez-Sánchez, Olga Rocío Flores-Chávez, Esther Ramírez-Moreno, José Arias-Rico, Felipe Arteaga-García, et al.

    Human immunodeficiency virus (HIV) infection has continued to be the subject of study since its discovery nearly 40 years ago. Significant advances in research and intake of antiretroviral therapy (ART) have slowed the progression and appearance of the disease symptoms and the incidence of concomitant diseases, which are the leading cause of death in HIV+ persons. However, the prolongation of ART is closely related to chronic degenerative diseases and pathologies caused by oxidative stress (OS) and alterations in lipid metabolism (increased cholesterol levels), both of which are conditions of ART. Therefore, recent research focuses on using natural therapies to diminish the effects of ART and HIV infection: regulating lipid metabolism and reducing OS status. The present review summarizes current information on OS and cholesterol metabolism in HIV+ persons and how the consumption of certain phytochemicals can modulate these. For this purpose, MEDLINE and SCOPUS databases were consulted to identify publications investigating HIV disease and natural therapies and their associated effects.